Steven Gannon Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Steven Gannon is of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 7,144 shares of XENE, which is worth approximately $206,104. The most recent transaction as insider was on May 14, 2025, when has been sold 5,144 shares (Common Shares) at a price of $12.57 per share, resulting in proceeds of $64,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.14K
257.2% 3M change
257.2% 12M change
Total Value Held $206,104

STEVEN GANNON Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 14 2025
BUY
Exercise of conversion of derivative security
$64,660 $12.57 p/Share
5,144 Added 41.86%
7,144 Common Shares
Mar 07 2024
SELL
Open market or private sale
$601,900 $46.3 p/Share
13,000 Reduced 86.67%
2,000 Common Shares

Also insider at

FUSN
Fusion Pharmaceuticals Inc. Healthcare
SG

Steven Gannon

Boston, MA

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE